Post-ERCP pancreatitis: Prevention, diagnosis and management

O Cahyadi, N Tehami, E de-Madaria, K Siau - Medicina, 2022 - mdpi.com
Endoscopic retrograde cholangiopancreatography (ERCP) carries a post-ERCP pancreatitis
(PEP) rate of 2–10%, which could be as high as 30–50% in high-risk cases. PEP is severe in …

Update on the management of acute pancreatitis

FF van den Berg, MA Boermeester - Current Opinion in Critical …, 2023 - journals.lww.com
More treatment modalities that are less invasive became available and a trend towards less
aggressive treatments (fluids, starvation, interventions, opiates) of acute pancreatitis is again …

American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations

JL Buxbaum, M Freeman, SK Amateau… - Gastrointestinal …, 2023 - giejournal.org
Methods This document was prepared by the Standards of Practice Committee of the ASGE
and was conceptualized and conducted according to the Grading of Recommendations …

Guidewire‐assisted cannulation of the common bile duct for the prevention of post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis

F Tse, J Liu, Y Yuan, P Moayyedi… - Cochrane Database of …, 2022 - cochranelibrary.com
Background Cannulation techniques have been recognized as being important in causing
post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) …

American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: methodology and review of evidence

JL Buxbaum, M Freeman, SK Amateau… - Gastrointestinal …, 2023 - giejournal.org
Methods The aim of this document is to describe the methodology used in this process and
to provide a detailed review of the evidence used to inform the guideline. It details the …

Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde …

VS Akshintala, CJS Weiland, FA Bhullar… - The Lancet …, 2021 - thelancet.com
Background Non-steroidal anti-inflammatory drugs (NSAIDs), intravenous fluid, pancreatic
stents, or combinations of these have been evaluated in randomised controlled trials (RCTs) …

Development and external validation of a nomogram for prediction of post-endoscopic retrograde cholangiopancreatography pancreatitis

R Fukuda, R Hakuta, Y Nakai, T Hamada, S Takaoka… - Pancreatology, 2023 - Elsevier
Background and aims Endoscopic retrograde cholangiopancreatography (ERCP) is widely
performed for management of pancreatobiliary diseases; however, post-ERCP pancreatitis …

Utilization pattern of prophylactic measures for prevention of post-ERCP pancreatitis: a National Survey Study

M Ashat, S Kandula, GA Cote, MA Gromski… - Gastrointestinal …, 2023 - Elsevier
Background and Aims Post-ERCP pancreatitis (PEP) is the most frequent adverse event of
ERCP. Various prophylactic measures are endorsed by the American Society for …

Prevention of post-ERCP complications

L Triki, A Tringali, M Arvanitakis, T Schepis - Best Practice & Research …, 2024 - Elsevier
Endoscopic retrograde cholangiopancreatography (ERCP) is a common endoscopic
procedure which plays a key role in the management of diseases of the bile ducts and the …

Universal prophylactic rectal nonsteroidal anti-inflammatory drugs with a policy of selective pancreatic duct stenting significantly reduce post-endoscopic retrograde …

A Agarwal, SJ Mahapatra, R Sethia, S Agarwal… - Indian Journal of …, 2023 - Springer
Background Although rectal nonsteroidal anti-inflammatory drugs (NSAIDs) have been
shown to be effective for the prevention of post-ERCP (endoscopic retrograde …